These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7438324

  • 1. Misonidazole in the preoperative and radical radiotherapy of bladder cancer.
    Awwad HK, El Merzabani MM, El Badawy S, Ezzat S, Akoush H, Abd El Moneim H, Saiid A, Soliman O, Khafagy M, Burgers MV.
    Cancer Clin Trials; 1980; 3(3):275-80. PubMed ID: 7438324
    [Abstract] [Full Text] [Related]

  • 2. Effect of misonidazole in preoperative irradiation for bladder cancer followed by total cystectomy.
    Ono K, Akuta K, Takahashi M, Abe M, Nishio Y, Okada K, Yoshida O.
    Radiat Med; 1989; 7(2):105-9. PubMed ID: 2508190
    [Abstract] [Full Text] [Related]

  • 3. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK, Hurst S, Begg AC, Brown JM.
    Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
    [Abstract] [Full Text] [Related]

  • 4. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N, Persky L.
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [Abstract] [Full Text] [Related]

  • 5. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
    Mohiuddin M, Kramer S, Phillips T, Soberon M, Forgione H.
    Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
    [Abstract] [Full Text] [Related]

  • 6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 7. The use of misonidazole in association with a three-fractions per day regimen in advanced head and neck epidermoid cancer. A pilot study.
    Awwad HK, Barsoum M, El Merzabani M, Omar S, El Badawy S, Ezzat S, El Baki HA, Zaki A.
    Am J Clin Oncol; 1983 Feb 15; 6(1):91-7. PubMed ID: 6301258
    [Abstract] [Full Text] [Related]

  • 8. Radical irradiation and misonidazole in the treatment of T2 grade III and T3 bladder cancer.
    Abratt RP, Sealy R, Tucker RD, Williams MA, Barnes DR, Johnson MB, Green JA, Cridland JS.
    Int J Radiat Oncol Biol Phys; 1983 May 15; 9(5):629-32. PubMed ID: 6853264
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience with misonidazole: high dose fractions versus daily low doses.
    Kogelnik HD.
    Cancer Clin Trials; 1980 May 15; 3(2):179-86. PubMed ID: 6253098
    [Abstract] [Full Text] [Related]

  • 10. The topical use of misonidazole in bladder cancer.
    Awwad HK, Abd El Moneim H, Abd El Baki H, Omar S, El Merzabani M, Farag HI.
    Prog Clin Biol Res; 1983 May 15; 132D():305-16. PubMed ID: 6634802
    [Abstract] [Full Text] [Related]

  • 11. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study.
    Smith JA, Crawford ED, Paradelo JC, Blumenstein B, Herschman BR, Grossman HB, Christie DW.
    J Urol; 1997 Mar 15; 157(3):805-7; discussion 807-8. PubMed ID: 9072571
    [Abstract] [Full Text] [Related]

  • 12. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B, Félix-Faure C, Davin JL, Choquenet C, Alfonsi M, Reboul F.
    Cancer Radiother; 1998 Apr 15; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [Abstract] [Full Text] [Related]

  • 13. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
    Koukourakis MI, Tsolos C, Touloupidis S.
    Urology; 2007 Feb 15; 69(2):245-50. PubMed ID: 17320657
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
    Vogt HG, Martin T, Kolotas C, Schneider L, Strassmann G, Zamboglou N.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
    [Abstract] [Full Text] [Related]

  • 15. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [Abstract] [Full Text] [Related]

  • 16. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ, Saunders MI, Dische S.
    Cancer; 1999 Oct 01; 86(7):1322-8. PubMed ID: 10506720
    [Abstract] [Full Text] [Related]

  • 17. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Oct 01; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 18. Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
    Awwad HK, Akhoush H, El-Merzabani M, El Badawy S, Barsoum M, el Baki HA.
    Radiother Oncol; 1984 Jun 01; 2(1):1-8. PubMed ID: 6095372
    [Abstract] [Full Text] [Related]

  • 19. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ, Sigdestad CP, Jovonovich JA.
    Cancer Clin Trials; 1980 Jun 01; 3(2):149-54. PubMed ID: 7428138
    [Abstract] [Full Text] [Related]

  • 20. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
    Koga F, Yoshida S, Kawakami S, Kageyama Y, Yokoyama M, Saito K, Fujii Y, Kobayashi T, Kihara K.
    Urology; 2008 Aug 01; 72(2):384-8. PubMed ID: 18455771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.